Dissertations in the news (Forbes)
13 April 2015
Is Pharmaceutical Productivity In Decline? Maybe Not. Hult’s paper (his dissertation to be precise) reframes this conundrum, redefining productivity in terms of (arguably) the outcome that matters for drugs – patient health. This has some intuitive appeal; after all, the real output for pharmaceutical firms isn’t the total number of drugs they put out, but how those drugs help the patients that take them. Phillipson and Hult put it best: “a single drug that cured all cancers would be immensely more valuable than 100 new molecules that treated acne.”
Read more at http://www.forbes.com/sites/theapothecary/2015/04/13/is-pharmaceutical-productivity-in-decline-maybe-not/